Enrique Grande Pulido-rekin lankidetzan egindako argitalpenak (3)

2019

  1. First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: A pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

    BMC Cancer, Vol. 19, Núm. 1

2015

  1. Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis

    BMC Cancer, Vol. 15, Núm. 1

2014

  1. The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status

    Angiogenesis, Vol. 17, Núm. 4, pp. 805-821